The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
Open accessAbstract
BACKGROUND: Increased expression of nerve growth factor in injured or inflamed tissue is associated with increased pain. This proof-of-concept study was designed to investigate the safety and analgesic efficacy of tanezumab, a humanized monoclonal antibody that binds and inhibits nerve growth factor. METHODS: We randomly assigned 450 patients with osteoarthritis of the knee to receive tanezumab (administered at a dose of 10, 25, 50, 100, or 200 μg per kilogram of body weight) or placebo on days 1 and 56. The primary efficacy measures were knee pain while walking and the patient's global assessment of response to therapy. We also assessed pain, stiffness, and physical function using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC); the rate of response using the criteria of the Outcome Measures for Rheumatology Committee and Osteoarthritis Research Society International Standing Committee for Clinical Trials Response Criteria Initiative (OMERACT-OARSI); and safety. RESULTS: When averaged over weeks 1 through 16, the mean reductions from baseline in knee pain while walking ranged from 45 to 62% with various doses of tanezumab, as compared with 22% with placebo (P<0.001). Tanezumab, as compared with placebo, was also associated with significantly greater improvements in the response to therapy as assessed with the use of the patients' global assessment measure (mean increases in score of 29 to 47% with various doses of tanezumab, as compared with 19% with placebo; P≤0.001). The rate of response according to the OMERACT-OARSI criteria ranged from 74 to 93% with tanezumab treatment, as compared with 44% with placebo (P<0.001). The rates of adverse events were 68% and 55% in the tanezumab and placebo groups, respectively. The most common adverse events among tanezumab-treated patients were headache (9% of the patients), upper respiratory tract infection (7%), and paresthesia (7%). CONCLUSIONS: In this proof-of-concept study, treatment with tanezumab was associated with a reduction in joint pain and improvement in function, with mild and moderate adverse events, among patients with moderate-to-severe osteoarthritis of the knee. (Funded by Rinat Neuroscience; ClinicalTrials.gov number, NCT00394563.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., Christy, W., Cooke, T. D., Greenwald, R., Hochberg, M., et al. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290816 · Cited by 6,777
Dworkin, R. H., Turk, D. C., Wyrwich, K. W., Beaton, D., Cleeland, C. S., Farrar, J. T., Haythornthwaite, J. A., Jensen, M. P., Kerns, R. D., Ader, D. N., et al. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.005 · Cited by 3,471
Zhang, W., Moskowitz, R. W., Nuki, G., Abramson, S., Altman, R. D., Arden, N., Bierma-Zeinstra, S., Brandt, K. D., Croft, P., Doherty, M., et al. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.12.013 · Cited by 2,796
Salaffi, F., Stancati, A., Silvestri, C. A., Ciapetti, A., & Grassi, W. (2004) · European Journal of Pain · doi:10.1016/j.ejpain.2003.09.004 · Cited by 1,724
The visual analogue pain intensity scale: what is moderate pain in millimetres?
Collins, S. L., Moore, A. R., & McQuay, H. J. (1997) · Pain · doi:10.1016/s0304-3959(97)00005-5 · Cited by 1,543
Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis
Clegg, D. O., Reda, D. J., Harris, C. L., Klein, M. A., O'Dell, J. R., Hooper, M. M., Bradley, J. D., Bingham, C. O., Weisman, M. H., Jackson, C. G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052771 · Cited by 1,329
Self-citationPham, T., van der Heijde, D., Altman, R. D., Anderson, J. J., Bellamy, N., Hochberg, M., Simon, L., Strand, V, Woodworth, T., & Dougados, M. (2004) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2004.02.001 · Cited by 849
Dillon, C. F., Rasch, E. K., Gu, Q., & Hirsch, R. (2006) · PubMed · Cited by 815
Cited by
Diagnosis and Treatment of Hip and Knee Osteoarthritis: A Review
Katz, J. N., Arant, K. R., & Loeser, R. F. (2021) · JAMA · doi:10.1001/jama.2020.22171 · Cited by 2,305
Balagué, F., Mannion, A. F., Pellisé, F., & Cedraschi, C. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60610-7 · Cited by 1,814
Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis
Robinson, W. H., Lepus, C. M., Wang, Q., Raghu, H., Mao, R., Lindstrom, T. M., & Sokolove, J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.136 · Cited by 1,438
Osteoarthritis: toward a comprehensive understanding of pathological mechanism
Chen, D., Shen, J., Zhao, W., Wang, T., Han, L., Hamilton, J. L., & Im, H.-J. (2017) · Bone Research · doi:10.1038/boneres.2016.44 · Cited by 1,187
Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
von Hehn, C. A., Baron, R., & Woolf, C. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.008 · Cited by 800
Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis
Mapp, P. I., & Walsh, D. A. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.80 · Cited by 638
Subchondral bone microenvironment in osteoarthritis and pain
Hu, Y., Chen, X., Wang, S., Jing, Y., & Su, J. (2021) · Bone Research · doi:10.1038/s41413-021-00147-z · Cited by 577
Perineural invasion and associated pain in pancreatic cancer
Bapat, A. A., Hostetter, G., Von Hoff, D. D., & Han, H. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3131 · Cited by 501
Current research on pharmacologic and regenerative therapies for osteoarthritis
Zhang, W., Ouyang, H., Dass, C. R., & Xu, J. (2016) · Bone Research · doi:10.1038/boneres.2015.40 · Cited by 495
Pain and immunity: implications for host defence
Baral, P., Udit, S., & Chiu, I. M. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0147-2 · Cited by 481
Chondrocyte dedifferentiation and osteoarthritis (OA)
Charlier, E., Deroyer, C., Ciregia, F., Malaise, O., Neuville, S., Plener, Z., Malaise, M., & de Seny, D. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.02.036 · Cited by 460
Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain
Zhu, S., Zhu, J., Zhen, G., Hu, Y., An, S., Li, Y., Zheng, Q., Chen, Z., Yang, Y., Wan, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121561 · Cited by 456
Clinical targeting of the TNF and TNFR superfamilies
Croft, M., Benedict, C. A., & Ware, C. F. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3930 · Cited by 456
Emerging pharmaceutical therapies for osteoarthritis
Latourte, A., Kloppenburg, M., & Richette, P. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00518-6 · Cited by 418
Postamputation pain: epidemiology, mechanisms, and treatment
Cohen, S., & Hsu (2013) · Journal of Pain Research · doi:10.2147/jpr.s32299 · Cited by 372
Mechanisms of Osteoarthritis (OA) Pain
O’Neill, T. W., & Felson, D. T. (2018) · Current Osteoporosis Reports · doi:10.1007/s11914-018-0477-1 · Cited by 334
Antagonism of Nerve Growth Factor-TrkA Signaling and the Relief of Pain
Mantyh, P. W., Koltzenburg, M., Mendell, L. M., Tive, L., Shelton, D. L., & Warner, D. S. (2011) · Anesthesiology · doi:10.1097/aln.0b013e31821b1ac5 · Cited by 331
Self-citationOsteochondral alterations in osteoarthritis
Suri, S., & Walsh, D. A. (2012) · Bone · doi:10.1016/j.bone.2011.10.010 · Cited by 331
Towards a mechanism-based approach to pain management in osteoarthritis
Malfait, A.-M., & Schnitzer, T. J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.138 · Cited by 310
Self-citationYuan, X. L., Meng, H. Y., Wang, Y. C., Peng, J., Guo, Q. Y., Wang, A. Y., & Lu, S. B. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2014.05.023 · Cited by 300
Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions
Cho, Y., Jeong, S., Kim, H., Kang, D., Lee, J., Kang, S.-B., & Kim, J.-H. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00710-y · Cited by 296
Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain
Hamilton, J. L., Nagao, M., Levine, B. R., Chen, D., Olsen, B. R., & Im, H.-J. (2016) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2828 · Cited by 287
Drewes, A. M., Olesen, A. E., Farmer, A. D., Szigethy, E., Rebours, V., & Olesen, S. S. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0135-7 · Cited by 272
Mechanisms of Chronic Pain in Osteoarthritis
Schaible, H.-G. (2012) · Current Rheumatology Reports · doi:10.1007/s11926-012-0279-x · Cited by 260
Nerve Growth Factor and Pain Mechanisms
Denk, F., Bennett, D. L., & McMahon, S. B. (2017) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-072116-031121 · Cited by 257
Peripheral changes in endometriosis-associated pain
Morotti, M., Vincent, K., Brawn, J., Zondervan, K. T., & Becker, C. M. (2014) · Human Reproduction Update · doi:10.1093/humupd/dmu021 · Cited by 198
Khan, K. S., Fawzy, M., & Chien, P. F. W. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14837 · Cited by 20
Benson, N., Matsuura, T., Smirnov, S., Demin, O., Jones, H. M., Dua, P., & van der Graaf, P. H. (2013) · Interface Focus · doi:10.1098/rsfs.2012.0071 · Cited by 20
“The observation from our sensitivity analysis that NGF is most influential in controlling dppERKnuc is consistent with the known behaviour of NGF-binding drugs such as mAbs in vitro [20], in animal models [21,22] and in man [23].”
Result
Metadata
- Authors
- Lane, N. E., Schnitzer, T. J., Birbara, C. A., Mokhtarani, M., Shelton, D. L., Smith, M. D., & Brown, M. T.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-14
- Volume
- 363
- Issue
- 16
- Pages
- 1521-1531
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2134905207
- Cited by
- 674
- References
- 38
- FWCI
- 33.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.